Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders

被引:0
|
作者
Wolfgang Jordan
Henrik Dobrowolny
Sabine Bahn
Hans-Gert Bernstein
Tanja Brigadski
Thomas Frodl
Berend Isermann
Volkmar Lessmann
Jürgen Pilz
Andrea Rodenbeck
Kolja Schiltz
Edzard Schwedhelm
Hayrettin Tumani
Jens Wiltfang
Paul C. Guest
Johann Steiner
机构
[1] Magdeburg Hospital GmbH,Department of Psychiatry and Psychotherapy
[2] University of Goettingen,Department of Psychiatry and Psychotherapy
[3] University of Magdeburg,Department of Psychiatry and Psychotherapy
[4] University of Cambridge,Department of Chemical Engineering and Biotechnology
[5] University of Magdeburg,Institute of Physiology
[6] Center for Behavioral Brain Sciences,Institute of Clinical Chemistry and Pathobiochemistry
[7] University of Magdeburg,Sleep Laboratory, Department of Pneumology
[8] Laboratory of Stress Monitoring,Department of Sleep Medicine and Clinical Chronobiology, Institute of Physiology, St. Hedwig Hospital, Charite
[9] Evangelisches Krankenhaus Goettingen-Weende gGmbH,Institute of Experimental and Clinical Pharmacology and Toxicology
[10] University of Berlin,Department of Neurology
[11] University Medical Center Hamburg-Eppendorf,Department of Biochemistry and Tissue Biology
[12] University of Ulm,undefined
[13] Fachklinik für Neurologie Dietenbronn,undefined
[14] German Center for Neurodegenerative Diseases (DZNE),undefined
[15] University of Campinas (UNICAMP),undefined
来源
European Archives of Psychiatry and Clinical Neuroscience | 2018年 / 268卷
关键词
Oxidative stress; Schizophrenia; Depression; 8-Iso-prostaglandin F2α; Isoprostane; Malondialdehyde; 8-OH-2-deoyxguanosine; Superoxide dismutase; Glutathione ; -transferase;
D O I
暂无
中图分类号
学科分类号
摘要
Oxidative stress and immune dysregulation have been linked to schizophrenia and depression. However, it is unknown whether these factors are related to the pathophysiology or whether they are an epiphenomenon. Inconsistent oxidative stress-related findings in previous studies may have resulted from the use of different biomarkers which show disparate aspects of oxidative stress. Additionally, disease severity, medication, smoking, endocrine stress axis activation and obesity are potential confounders. In order to address some of these shortcomings, we have analyzed a broader set of oxidative stress biomarkers in our exploratory study, including urinary 8-iso-prostaglandin F2α (8-iso-PGF2α), 8-OH-2-deoyxguanosine (8-OH-2-dG), and blood levels of malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione S-transferase (GST) in acutely ill drug-naïve first episode patients with schizophrenia (n = 22), major depression (n = 18), and controls (n = 43). Possible confounding factors were considered, and patients were followed-up after 6 weeks of treatment. No differences were observed regarding 8-OH-2-dG, MDA and GST. At baseline, 8-iso-PGF2α levels were higher in patients with schizophrenia (p = 0.004) and major depression (p = 0.037), with a trend toward higher SOD concentrations in schizophrenia (p = 0.053). After treatment, schizophrenia patients showed a further increase in 8-iso-PGF2α (p = 0.016). These results were not related to age, sex, disease severity, medication or adipose tissue mass. However, 8-iso-PGF2α was associated with smoking, endocrine stress axis activation, C-reactive protein levels and low plasma concentrations of brain-derived neurotrophic factor. This study suggests a role of lipid peroxidation particularly in drug-naïve acutely ill schizophrenia patients and highlights the importance of taking into account other confounding factors in biomarker studies.
引用
收藏
页码:129 / 143
页数:14
相关论文
共 50 条
  • [41] Oxidative stress in drug naive first episode psychosis and antioxidant effects of risperidone
    Noto, Cristiano
    Ota, Vanessa Kiyomi
    Gadelha, Ary
    Noto, Mariane Nunes
    Barbosa, Decio Sabbatini
    Bonifacio, Kamila Landucci
    Nunes, Sandra Odebrecht
    Cordeiro, Quirino
    Belangero, Sintia Iole
    Bressan, Rodrigo Affonseca
    Maes, Michael
    Brietzke, Elisa
    JOURNAL OF PSYCHIATRIC RESEARCH, 2015, 68 : 210 - 216
  • [42] Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patients
    Kuan Zeng
    Shuo Wang
    Lin Zhang
    Yanting Zhang
    Jun Ma
    Annals of General Psychiatry, 22
  • [43] Plasma linoelaidyl carnitine levels positively correlated with symptom improvement in olanzapine-treated first-episode drug-naïve schizophrenia
    Xuan Wang
    Meihong Xiu
    Keqiang Wang
    Xiuru Su
    Xirong Li
    Fengchun Wu
    Metabolomics, 18
  • [44] Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes
    Da Chun Chen
    Jing Wang
    Bo Wang
    Sheng Chang Yang
    Chong Xi Zhang
    You Lan Zheng
    Yan Li Li
    Ning Wang
    Ke Bing Yang
    Mei Hong Xiu
    Thomas R. Kosten
    Xiang Yang Zhang
    Psychopharmacology, 2009, 207 : 375 - 380
  • [45] Alterations in Spontaneous Brain Activity in Drug-Na?ve First-Episode Schizophrenia: An Anatomical/Activation Likelihood Estimation Meta-Analysis
    Qiu, Xiaolei
    Zhang, Rongrong
    Wen, Lu
    Jiang, Fuli
    Mao, Hongjun
    Yan, Wei
    Xie, Shiping
    Pan, Xinming
    PSYCHIATRY INVESTIGATION, 2022, 19 (08) : 606 - +
  • [46] Targeted metabolomics-based understanding of the sleep disturbances in drug-naïve patients with schizophrenia
    Yan, Huiming
    Li, Gang
    Zhang, Xue
    Zhang, Chuhao
    Li, Meijuan
    Qiu, Yuying
    Sun, Wei
    Dong, Yeqing
    Li, Shen
    Li, Jie
    BMC PSYCHIATRY, 2024, 24 (01)
  • [47] Prediction of treatment response in drug-naïve schizophrenia patients from the perspective of targeted metabolomics
    Wang, Shuo
    Dong, Yeqing
    Qiu, Yuying
    Sun, Xiaoxiao
    Jiang, Changyong
    Su, Qiao
    Li, Meijuan
    Li, Jie
    SCHIZOPHRENIA RESEARCH, 2025, 278 : 9 - 16
  • [48] Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study
    Xiaoe Lang
    Mei Xue
    Xiaocui Zang
    Fengchun Wu
    Meihong Xiu
    Xiangyang Zhang
    Journal of Translational Medicine, 21
  • [49] Association of dopamine-based genetic risk score with dynamic low-frequency fluctuations in first-episode drug-naïve schizophrenia
    Yafei Kang
    Youming Zhang
    Kexin Huang
    Zhenhong Wang
    Brain Imaging and Behavior, 2023, 17 : 584 - 594
  • [50] The different impacts of functional network centrality and connectivity on the complexity of brain signals in healthy control and first-episode drug-naïve patients with major depressive disorder
    Ji, Shanling
    An, Wei
    Zhang, Jing
    Zhou, Cong
    Liu, Chuanxin
    Yu, Hao
    BRAIN IMAGING AND BEHAVIOR, 2025, 19 (01) : 111 - 123